Cargando…

The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity

Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Dalia, Tencerova, Michaela, Figeac, Florence, Kassem, Moustapha, Jafari, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520254/
https://www.ncbi.nlm.nih.gov/pubmed/36187112
http://dx.doi.org/10.3389/fendo.2022.981487
_version_ 1784799582318755840
author Ali, Dalia
Tencerova, Michaela
Figeac, Florence
Kassem, Moustapha
Jafari, Abbas
author_facet Ali, Dalia
Tencerova, Michaela
Figeac, Florence
Kassem, Moustapha
Jafari, Abbas
author_sort Ali, Dalia
collection PubMed
description Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men.
format Online
Article
Text
id pubmed-9520254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95202542022-09-30 The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity Ali, Dalia Tencerova, Michaela Figeac, Florence Kassem, Moustapha Jafari, Abbas Front Endocrinol (Lausanne) Endocrinology Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520254/ /pubmed/36187112 http://dx.doi.org/10.3389/fendo.2022.981487 Text en Copyright © 2022 Ali, Tencerova, Figeac, Kassem and Jafari https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ali, Dalia
Tencerova, Michaela
Figeac, Florence
Kassem, Moustapha
Jafari, Abbas
The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title_full The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title_fullStr The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title_full_unstemmed The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title_short The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
title_sort pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520254/
https://www.ncbi.nlm.nih.gov/pubmed/36187112
http://dx.doi.org/10.3389/fendo.2022.981487
work_keys_str_mv AT alidalia thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT tencerovamichaela thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT figeacflorence thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT kassemmoustapha thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT jafariabbas thepathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT alidalia pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT tencerovamichaela pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT figeacflorence pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT kassemmoustapha pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity
AT jafariabbas pathophysiologyofosteoporosisinobesityandtype2diabetesinagingwomenandmenthemechanismsandrolesofincreasedbonemarrowadiposity